Peripheral neuropathy - Treatment with cisplatin Factor
Last reviewed for CCPS 15 March 2006.
Investigative Documents
Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]
Preliminary questions [32953]
there is some evidence that treatment with cisplatin may be a factor in the development of the condition under consideration.32955 the veteran was treated with cisplatin for an illness or injury which is identifiable.
for the identified illness or injury, the veteran was treated with cisplatin within the six months immediately before the clinical onset of the condition under consideration.32957 — the veteran has established the causal connection between the treatment with cisplatin and VEA service for the clinical onset of peripheral neuropathy.
32958 — the veteran has established the causal connection between the treatment with cisplatin and operational service for the clinical onset of peripheral neuropathy.
or
32959 — the veteran has established the causal connection between the treatment with cisplatin and eligible service for the clinical onset of peripheral neuropathy.
Clinical onset and operational service [32958]
32960 — the identified illness or injury which required treatment with cisplatin is causally related to operational service.
Clinical onset and eligible service [32959]
32961 — the identified illness or injury which required treatment with cisplatin is causally related to eligible service.